Conversely, glioblastoma patients harboring BRAF exon 15 p.V600E have the same prognosis as wild-type patients, despite the prevalence of epithelioid morphology without isocitrate dehydrogenase (IDH) alterations [115]. The gene discussed is BRAF; the disease is glioblastoma.